|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 216.18 USD | +1.84% |
|
+2.44% | +11.01% |
| 16/07 | CPC Biotech, Part of PSG and Dover Launches RevolveSD Series One-Inch Single-Use Sterile Disconnect for Bioprocessing | CI |
| 10/07 | Goldman Sachs Adjusts Price Target on Dover to $255 From $263 | MT |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 8.38 | 8.32 | 7.97 | 6.76 | 6.96 | |||||
Return on Total Capital | 11.55 | 11.29 | 10.44 | 8.53 | 8.56 | |||||
Return On Equity % | 29.67 | 25.14 | 22.5 | 23.22 | 15.29 | |||||
Return on Common Equity | 29.67 | 25.14 | 22.5 | 23.22 | 15.29 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 37.72 | 36.09 | 36.79 | 38.69 | 40.16 | |||||
SG&A Margin | 19.15 | 17.51 | 18.16 | 20.09 | 20.27 | |||||
EBITDA Margin % | 20.25 | 20.27 | 20.57 | 21.03 | 22.54 | |||||
EBITA Margin % | 18.38 | 18.52 | 18.71 | 19.03 | 20.45 | |||||
EBIT Margin % | 16.58 | 16.65 | 16.81 | 16.67 | 17.85 | |||||
Income From Continuing Operations Margin % | 14.21 | 12.52 | 12.52 | 18.07 | 13.56 | |||||
Net Income Margin % | 14.21 | 12.52 | 12.52 | 34.82 | 13.52 | |||||
Net Avail. For Common Margin % | 14.21 | 12.52 | 12.52 | 18.07 | 13.56 | |||||
Normalized Net Income Margin | 9.75 | 9.68 | 9.78 | 9.92 | 11.02 | |||||
Levered Free Cash Flow Margin | 9.41 | 5.37 | 10.82 | 14.67 | 10.61 | |||||
Unlevered Free Cash Flow Margin | 10.25 | 6.23 | 11.79 | 15.73 | 11.46 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.81 | 0.8 | 0.76 | 0.65 | 0.62 | |||||
Fixed Assets Turnover | 7.21 | 7.31 | 6.91 | 6.5 | 6.36 | |||||
Receivables Turnover (Average Receivables) | 6.3 | 5.89 | 5.66 | 5.7 | 5.81 | |||||
Inventory Turnover (Average Inventory) | 4.86 | 4.25 | 4.12 | 4.15 | 4.01 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.36 | 1.23 | 1.4 | 2.04 | 1.79 | |||||
Quick Ratio | 0.78 | 0.69 | 0.77 | 1.47 | 1.22 | |||||
Operating Cash Flow to Current Liabilities | 0.5 | 0.29 | 0.55 | 0.34 | 0.53 | |||||
Days Sales Outstanding (Average Receivables) | 57.96 | 61.92 | 64.44 | 64.2 | 62.78 | |||||
Days Outstanding Inventory (Average Inventory) | 75.12 | 85.84 | 88.68 | 88.2 | 91.12 | |||||
Average Days Payable Outstanding | 66.63 | 69.63 | 71.22 | 65.59 | 63.29 | |||||
Cash Conversion Cycle (Average Days) | 66.45 | 78.13 | 81.9 | 86.8 | 90.61 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 79.03 | 90.88 | 72.27 | 45.49 | 48.4 | |||||
Total Debt / Total Capital | 44.14 | 47.61 | 41.95 | 31.26 | 32.62 | |||||
LT Debt/Equity | 75.42 | 72.66 | 62.09 | 38.97 | 38.09 | |||||
Long-Term Debt / Total Capital | 42.13 | 38.07 | 36.04 | 26.78 | 25.67 | |||||
Total Liabilities / Total Assets | 59.73 | 60.66 | 55 | 44.41 | 44.83 | |||||
EBIT / Interest Expense | 12.33 | 12.17 | 10.8 | 9.84 | 13.16 | |||||
EBITDA / Interest Expense | 15.8 | 15.52 | 13.9 | 13.11 | 17.51 | |||||
(EBITDA - Capex) / Interest Expense | 14.18 | 13.62 | 12.44 | 11.83 | 15.5 | |||||
Total Debt / EBITDA | 1.97 | 2.16 | 2.02 | 1.84 | 1.86 | |||||
Net Debt / EBITDA | 1.74 | 1.94 | 1.8 | 0.77 | 0.99 | |||||
Total Debt / (EBITDA - Capex) | 2.2 | 2.46 | 2.26 | 2.04 | 2.11 | |||||
Net Debt / (EBITDA - Capex) | 1.94 | 2.22 | 2.02 | 0.85 | 1.12 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 18.3 | 7.6 | -0.82 | 0.8 | 4.48 | |||||
Gross Profit, 1 Yr. Growth % | 19.65 | 2.94 | 1.09 | 3.8 | 8.46 | |||||
EBITDA, 1 Yr. Growth % | 26.77 | 7.71 | 0.67 | 3.34 | 12.01 | |||||
EBITA, 1 Yr. Growth % | 29.46 | 8.38 | 0.2 | 3.47 | 12.27 | |||||
EBIT, 1 Yr. Growth % | 33.24 | 8.09 | 0.12 | 1.56 | 11.92 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 64.43 | -5.2 | -0.8 | 48.32 | -21.61 | |||||
Net Income, 1 Yr. Growth % | 64.43 | -5.2 | -0.8 | 155.21 | -59.44 | |||||
Normalized Net Income, 1 Yr. Growth % | 39.99 | 6.87 | 0.19 | 4.79 | 16.06 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 64.68 | -4.13 | 1.35 | 50.37 | -21.01 | |||||
Accounts Receivable, 1 Yr. Growth % | 17.94 | 12.44 | -5 | 2.68 | 2.23 | |||||
Inventory, 1 Yr. Growth % | 42.51 | 14.74 | -10.33 | 0.07 | 11.18 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 5.52 | 6.71 | 3.3 | 0.93 | 12.73 | |||||
Total Assets, 1 Yr. Growth % | 13.68 | 4.74 | 4.15 | 10.23 | 7.3 | |||||
Tangible Book Value, 1 Yr. Growth % | -2.36 | -0.69 | -26.67 | -147.89 | -53.89 | |||||
Common Equity, 1 Yr. Growth % | 23.74 | 2.31 | 19.14 | 36.18 | 6.49 | |||||
Cash From Operations, 1 Yr. Growth % | 1 | -27.79 | 65.86 | -44 | 78.2 | |||||
Capital Expenditures, 1 Yr. Growth % | 3.48 | 28.87 | -12.84 | -8.65 | 31.47 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -6.49 | -38.6 | 99.81 | 38.95 | -24.42 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -6.37 | -34.65 | 87.85 | 35.39 | -23.88 | |||||
Dividend Per Share, 1 Yr. Growth % | 1.02 | 1 | 1 | 0.99 | 0.98 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 5.26 | 12.82 | 3.3 | -0.63 | 2.62 | |||||
Gross Profit, 2 Yr. CAGR % | 6.5 | 10.98 | 2.01 | 1.45 | 6.11 | |||||
EBITDA, 2 Yr. CAGR % | 9.72 | 16.85 | 4.13 | 0.49 | 7.59 | |||||
EBITA, 2 Yr. CAGR % | 10.22 | 18.45 | 4.21 | 0.18 | 7.78 | |||||
EBIT, 2 Yr. CAGR % | 11.33 | 20.01 | 4.03 | -1 | 6.62 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 28.75 | 24.85 | -3.03 | 18.92 | 7.83 | |||||
Net Income, 2 Yr. CAGR % | 28.75 | 24.85 | -3.03 | 59.11 | 1.74 | |||||
Normalized Net Income, 2 Yr. CAGR % | 14.52 | 22.31 | 3.98 | 0.34 | 10.28 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 29.57 | 25.65 | -1.43 | 21.01 | 8.99 | |||||
Accounts Receivable, 2 Yr. CAGR % | 5.02 | 15.15 | 3.35 | -5.08 | 2.46 | |||||
Inventory, 2 Yr. CAGR % | 21.55 | 27.87 | 1.43 | -8.47 | 5.47 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 6.27 | 6.11 | 4.99 | -0.23 | 6.67 | |||||
Total Assets, 2 Yr. CAGR % | 9.55 | 9.11 | 4.44 | 7.14 | 8.75 | |||||
Tangible Book Value, 2 Yr. CAGR % | -2.15 | -1.53 | -14.66 | -47.82 | -53.01 | |||||
Common Equity, 2 Yr. CAGR % | 17.54 | 12.52 | 10.4 | 27.37 | 20.42 | |||||
Cash From Operations, 2 Yr. CAGR % | 8.65 | -14.6 | 9.43 | -3.62 | -0.1 | |||||
Capital Expenditures, 2 Yr. CAGR % | -4.19 | 15.48 | 5.98 | -10.91 | 9.59 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 5.66 | -24.23 | 10.77 | 70.27 | 2.48 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 4.3 | -21.78 | 10.8 | 61.91 | 1.52 | |||||
Dividend Per Share, 2 Yr. CAGR % | 1.28 | 1.01 | 1 | 0.99 | 0.98 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 4.18 | 6.04 | 8.08 | -0.68 | 1.04 | |||||
Gross Profit, 3 Yr. CAGR % | 5 | 5.3 | 7.58 | 0.16 | 3.73 | |||||
EBITDA, 3 Yr. CAGR % | 10.58 | 9.04 | 11.19 | 0.58 | 4.19 | |||||
EBITA, 3 Yr. CAGR % | 11.61 | 9.6 | 12.03 | 0.47 | 4.05 | |||||
EBIT, 3 Yr. CAGR % | 13.29 | 10.24 | 12.97 | -0.51 | 3.13 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 23.88 | 16.26 | 15.64 | 7.6 | 3.5 | |||||
Net Income, 3 Yr. CAGR % | 25.37 | 16.26 | 15.64 | 33.89 | 0.89 | |||||
Normalized Net Income, 3 Yr. CAGR % | 16.31 | 11.91 | 14.44 | 0.21 | 5.33 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 25.78 | 17.19 | 16.96 | 9.24 | 4.97 | |||||
Accounts Receivable, 3 Yr. CAGR % | 3.07 | 7.44 | 8 | 0.43 | -2.7 | |||||
Inventory, 3 Yr. CAGR % | 16.73 | 19.24 | 13.6 | -1.31 | -2.34 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 11.78 | 6.42 | 5.17 | 2.03 | 3.91 | |||||
Total Assets, 3 Yr. CAGR % | 7.54 | 7.92 | 7.43 | 6.34 | 7.2 | |||||
Tangible Book Value, 3 Yr. CAGR % | -5.41 | -1.67 | -10.74 | -35.34 | -49.93 | |||||
Common Equity, 3 Yr. CAGR % | 14.81 | 12.22 | 14.68 | 18.4 | 19.99 | |||||
Cash From Operations, 3 Yr. CAGR % | 11.79 | -5.19 | 6.55 | -12.47 | 18.29 | |||||
Capital Expenditures, 3 Yr. CAGR % | 0.09 | 5.76 | 5.14 | -0.77 | 1.43 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 7.94 | -11.82 | 4.69 | 15.15 | 29.88 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 6.37 | -10.75 | 4.75 | 14.54 | 25.9 | |||||
Dividend Per Share, 3 Yr. CAGR % | 1.55 | 1.19 | 1.01 | 1 | 0.99 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 5.52 | 4.52 | 3.83 | 1.65 | 3.9 | |||||
Gross Profit, 5 Yr. CAGR % | 5.96 | 3.82 | 3.8 | 2.65 | 5.45 | |||||
EBITDA, 5 Yr. CAGR % | 10.29 | 8.51 | 7.95 | 4.14 | 7.63 | |||||
EBITA, 5 Yr. CAGR % | 11.02 | 9.23 | 8.59 | 4.26 | 8.07 | |||||
EBIT, 5 Yr. CAGR % | 12.37 | 10.42 | 9.49 | 4.07 | 7.99 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 17.48 | 7.37 | 12.32 | 15.61 | 9.93 | |||||
Net Income, 5 Yr. CAGR % | 17.17 | 5.59 | 13.13 | 31.81 | 9.86 | |||||
Normalized Net Income, 5 Yr. CAGR % | 15 | 12.7 | 10.99 | 5.5 | 10.12 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 19.25 | 9.42 | 14.09 | 16.96 | 11.14 | |||||
Accounts Receivable, 5 Yr. CAGR % | 1.44 | 5.03 | 3.18 | 2.24 | 4.08 | |||||
Inventory, 5 Yr. CAGR % | 6.47 | 15.08 | 10.35 | 7.27 | 8.78 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 3.56 | 8.81 | 9.01 | 3.7 | 4.79 | |||||
Total Assets, 5 Yr. CAGR % | 0.56 | 0.44 | 6.29 | 7.61 | 7.96 | |||||
Tangible Book Value, 5 Yr. CAGR % | -7.59 | 23.99 | -9.23 | -23.68 | -34.37 | |||||
Common Equity, 5 Yr. CAGR % | 1.97 | -0.45 | 13.02 | 18.05 | 16.94 | |||||
Cash From Operations, 5 Yr. CAGR % | 5.28 | -0.73 | 10.84 | -4.56 | 3.84 | |||||
Capital Expenditures, 5 Yr. CAGR % | 4.2 | 5.38 | 2.41 | -2.15 | 5.86 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 3.47 | -11.14 | 9.06 | 11.26 | 1.53 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 2.62 | -10.37 | 8.12 | 10.33 | 1.38 | |||||
Dividend Per Share, 5 Yr. CAGR % | 2.96 | 2.01 | 1.33 | 1.11 | 1 |
- Stock Market
- Stocks
- DOV Stock
- Financials Dover Corporation
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















